Article | February 25, 2021

Empowering Medical Coders With AI To Increase Efficiency And Accuracy

By Walker Bradham and Mary Varghese Presti

Medical Coding And New FDA Guidelines For WHODrug B3/C3

These days, every aspect of the drug development process is being scrutinized by pharma companies seeking to streamline their operations. Clinical trials, in particular, were a common target in 2020 as firms scrambled to find alternatives to their traditional models amidst the COVID-19 pandemic.

As anyone involved with clinical trial operations or data management can tell you, medical coding is an often-overlooked element of the process that is ripe for improvement. To understand the importance of this function, consider the example of a COVID-19 vaccine trial being paused due to patients with unexplained illnesses. “The researchers are looking for expected or unexpected reactions to a given treatment to make decisions such as halting or adjusting a trial,” explains Walker Bradham, an Offering Manager at IBM Watson Health who works extensively on IBM Clinical Development, the company’s CDMS (clinical data management system). “The documentation regarding any adverse events or medical history that can cause those types of trial revisions originates with the efforts of a medical coder.”

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: